Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

AbbVie Is More Than Just a Portfolio of Drugs and Acquisitions

With AbbVie's buyout of Allergan officially finalized, ABBV stock has moved significantly higher since then. However, ABBV is so much more than this headline event.

Visa’s Fortunes Are Tied to a Tenuous Jobs Market

Consumer spending has shifted, but may slow down even more if the United States has a jobless recovery, raising skepticism toward V stock.

Fair Warning: The Clock Is Ticking on Netflix Stock Growth

NFLX stock is up nearly 50% during the Covid-19 pandemic. But with the CEO warning of slower growth, is the stock still a buy?

When the Virus Fog Lifts, Will Delta Air Lines Stock Be Flying Again?

It may be tempting to take a chance on Delta. But while DAL stock may be near a bottom, growth looks to be many years away.

Investors Should Socially Distance From Lyft Stock

The worst is yet to come for Lyft stock. As the economy re-opens, there is reason to believe Lyft's customers may not return.